| All Patients | Outcome | ||
---|---|---|---|---|
Survivor | Non-survivor | Sign | ||
Total number of patients (%) | 101 (100) | 67 (66.3) | 34 (33.7) | Â |
STEMI, no (%) | 91 (90.1) | 58 (57.4) | 33 (32.7) | 0.158 |
MI territory | ||||
 Anterior, no (%) | 61 (61.0) | 42 (42.0) | 19 (19.0) | 0.667 |
 Inferior, no (%) | 38 (38.0) | 26 (26.0) | 12 (12.0) | 1.000 |
 Lateral, no (%) | 32 (32.0) | 22 (22.0) | 10 (10.0) | 1.000 |
 RV involvement, no (%) | 5 (5.0) | 1 (1.0) | 4 (4.0) | 0.040 |
Peak troponin, ng/L med (IQR) | 38.9 (13.7–40.0) | 26.8 (10.9–40.0) | 40.0 (19.1–626.0) | 0.146 |
LV systolic function | ||||
 Normal, no (%) | 10 (11.6) | 8 (9.3) | 2 (2.3) | 0.488 |
 Mild dysfunction, no (%) | 26 (30.2) | 21 (24.4) | 5 (5.8) | 0.093 |
 Moderate dysfunction, no (%) | 22 (25.6) | 17 (19.8) | 5 (5.8) | 0.309 |
 Severe dysfunction, no (%) | 28 (32.6) | 14 (16.3) | 14 (16.3) | 0.037 |
Thrombolysis pre-PPCI, no (%) | 1 (1.0) | 1 (1.0) | 0 (0.0) | 1.000 |
Angiogram, (successful completion) no (%) | 99 (98.0) | 67 (66.3) | 32 (31.7) | 0.111 |
PCI performed (successful completion), no (%) | 91 (90.1) | 62 (61.4) | 29 (28.7) | 0.298 |
IABP in cath lab, no (%) | 50 (49.5) | 28 (27.7) | 22 (21.8) | 0.036 |
Number of diseased vessels, med (IQR) | 2 (1–3) | 2 (1–3) | 2 (2–3) | 0.514 |
Left main stem disease, no (%) | 14 (14.1) | 8 (8.1) | 6 (6.1) | 0.371 |
TIMI flow, med (IQR) | 3 (2–3) | 3 (2–3) | 3 (2–3) | 0.862 |
Symptom onset to device time (min, med (IQR) | 210 (155–332) | 219 (159–328) | 200 (150–350) | 0.665 |